S&P 500   4,117.86
DOW   33,949.01
QQQ   304.37
Is SoundHound Voice AI the Next Big Thing?
Free ebook: 3 Rules to Picking the Right Stocks (Ad)pixel
CVS Health Corporation Is Coiled And Ready To Spring Higher 
Double Meat: Beyond Meat Could Be 2023’s Next Two-Bagger
Free Stock Analysis Report: See the Right Way to Analyze Stocks (Ad)pixel
3 Solar-Energy Stocks Setting Up In Bullish Bases
V.F. Corporation Is A High-Yield Bargain Despite Dividend Cut
Free Stock Analysis Report: See the Right Way to Analyze Stocks (Ad)pixel
TG Therapeutics Stock 300% Rally Has Legs Yet
Daqo New Energy Charged Up For New Highs
S&P 500   4,117.86
DOW   33,949.01
QQQ   304.37
Is SoundHound Voice AI the Next Big Thing?
Free ebook: 3 Rules to Picking the Right Stocks (Ad)pixel
CVS Health Corporation Is Coiled And Ready To Spring Higher 
Double Meat: Beyond Meat Could Be 2023’s Next Two-Bagger
Free Stock Analysis Report: See the Right Way to Analyze Stocks (Ad)pixel
3 Solar-Energy Stocks Setting Up In Bullish Bases
V.F. Corporation Is A High-Yield Bargain Despite Dividend Cut
Free Stock Analysis Report: See the Right Way to Analyze Stocks (Ad)pixel
TG Therapeutics Stock 300% Rally Has Legs Yet
Daqo New Energy Charged Up For New Highs
S&P 500   4,117.86
DOW   33,949.01
QQQ   304.37
Is SoundHound Voice AI the Next Big Thing?
Free ebook: 3 Rules to Picking the Right Stocks (Ad)pixel
CVS Health Corporation Is Coiled And Ready To Spring Higher 
Double Meat: Beyond Meat Could Be 2023’s Next Two-Bagger
Free Stock Analysis Report: See the Right Way to Analyze Stocks (Ad)pixel
3 Solar-Energy Stocks Setting Up In Bullish Bases
V.F. Corporation Is A High-Yield Bargain Despite Dividend Cut
Free Stock Analysis Report: See the Right Way to Analyze Stocks (Ad)pixel
TG Therapeutics Stock 300% Rally Has Legs Yet
Daqo New Energy Charged Up For New Highs
S&P 500   4,117.86
DOW   33,949.01
QQQ   304.37
Is SoundHound Voice AI the Next Big Thing?
Free ebook: 3 Rules to Picking the Right Stocks (Ad)pixel
CVS Health Corporation Is Coiled And Ready To Spring Higher 
Double Meat: Beyond Meat Could Be 2023’s Next Two-Bagger
Free Stock Analysis Report: See the Right Way to Analyze Stocks (Ad)pixel
3 Solar-Energy Stocks Setting Up In Bullish Bases
V.F. Corporation Is A High-Yield Bargain Despite Dividend Cut
Free Stock Analysis Report: See the Right Way to Analyze Stocks (Ad)pixel
TG Therapeutics Stock 300% Rally Has Legs Yet
Daqo New Energy Charged Up For New Highs
NASDAQ:JAGX

Jaguar Health - JAGX Stock Forecast, Price & News

$4.19
-0.30 (-6.68%)
(As of 02/8/2023 12:00 AM ET)
Add
Compare
Today's Range
$4.16
$4.52
50-Day Range
$0.08
$5.43
52-Week Range
$4.16
$61.49
Volume
303,075 shs
Average Volume
410,867 shs
Market Capitalization
$8.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
JAGX stock logo

About Jaguar Health (NASDAQ:JAGX) Stock

Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. The firm focuses on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. It operates through the Human Health and Animal Health segments. The Human Health segment manufactures human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment commercializes prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.

Receive JAGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Jaguar Health and its competitors with MarketBeat's FREE daily newsletter.

JAGX Stock News Headlines

Biden Likely HATES This Video
Biden just signed an order that wages WAR on every American Patriot. It’s an order that could make it 100% legal for the government to track your every move… That’s why Biden would HATE this video. Inside, it explains – in detail – how to beat back the government…
StockNews.com Begins Coverage on Jaguar Health (NASDAQ:JAGX)
Laser breakthrough could send stock soaring 2,476%
Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%...Boeing soared 4,238%...L3Harris shot up 1,628%...
Is Jaguar Health (JAGX) Stock Really Up 6,800%?
See More Headlines
Receive JAGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Jaguar Health and its competitors with MarketBeat's FREE daily newsletter.

JAGX Company Calendar

Last Earnings
11/14/2022
Today
2/08/2023
Next Earnings (Estimated)
3/10/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:JAGX
Fax
N/A
Employees
52
Year Founded
N/A

Profitability

Net Income
$-52,600,000.00
Net Margins
-502.84%
Pretax Margin
-505.58%

Debt

Sales & Book Value

Annual Sales
$4.34 million
Book Value
$17.66 per share

Miscellaneous

Free Float
1,913,000
Market Cap
$8.09 million
Optionable
Not Optionable
Beta
1.65

Key Executives

  • Lisa A. Conte
    President, Chief Executive Officer & Director
  • Carol R. Lizak
    Chief Financial Officer
  • Pravin Ramsewak Chaturvedi
    Chief Scientific Officer
  • Jonathan S. Wolin
    Chief of Staff & Chief Compliance Officer
  • Karen J. Brunke
    Executive VP-Corporate & Business Development













JAGX Stock - Frequently Asked Questions

How have JAGX shares performed in 2023?

Jaguar Health's stock was trading at $0.0869 at the start of the year. Since then, JAGX shares have increased by 4,779.2% and is now trading at $4.24.
View the best growth stocks for 2023 here
.

When is Jaguar Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, March 10th 2023.
View our JAGX earnings forecast
.

How were Jaguar Health's earnings last quarter?

Jaguar Health, Inc. (NASDAQ:JAGX) announced its quarterly earnings results on Monday, November, 14th. The biotechnology company reported ($0.12) EPS for the quarter. The biotechnology company had revenue of $3.15 million for the quarter. Jaguar Health had a negative trailing twelve-month return on equity of 823.56% and a negative net margin of 502.84%.

When did Jaguar Health's stock split?

Jaguar Health shares reverse split on Wednesday, September 8th 2021. The 1-3 reverse split was announced on Wednesday, September 8th 2021. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, September 8th 2021. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split.

What other stocks do shareholders of Jaguar Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Jaguar Health investors own include Biocept (BIOC), Sorrento Therapeutics (SRNE), Trevena (TRVN), Vaxart (VXRT), Purple Biotech (KTOV), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), Biopharmx (BPMX), Cara Therapeutics (CARA) and Conatus Pharmaceuticals (CNAT).

When did Jaguar Health IPO?

(JAGX) raised $22 million in an initial public offering on Wednesday, May 13th 2015. The company issued 3,200,000 shares at a price of $7.00 per share. Aegis Capital Corp served as the underwriter for the IPO and CRT Capital and Feltl and Company were co-managers.

What is Jaguar Health's stock symbol?

Jaguar Health trades on the NASDAQ under the ticker symbol "JAGX."

Who are Jaguar Health's major shareholders?

Jaguar Health's stock is owned by a number of retail and institutional investors. Top institutional investors include Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%).
View institutional ownership trends
.

How do I buy shares of Jaguar Health?

Shares of JAGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Jaguar Health's stock price today?

One share of JAGX stock can currently be purchased for approximately $4.24.

How much money does Jaguar Health make?

Jaguar Health (NASDAQ:JAGX) has a market capitalization of $8.18 million and generates $4.34 million in revenue each year. The biotechnology company earns $-52,600,000.00 in net income (profit) each year or ($71.4286) on an earnings per share basis.

How can I contact Jaguar Health?

Jaguar Health's mailing address is 201 MISSION STREET SUITE 2375, SAN FRANCISCO CA, 94105. The official website for the company is www.jaguaranimalhealth.com. The biotechnology company can be reached via phone at (415) 371-8300.

This page (NASDAQ:JAGX) was last updated on 2/9/2023 by MarketBeat.com Staff